Anticancer Effect of Co(III) Complex of a Thiourea Derivative on Inhibiting Breast Cancer Cell Proliferation Using In Silico and In Vitro Evaluations
ChemMedChem · 28.10.2026 · 21 (20)
DOI: 10.1002/cmdc.70544 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 22.10.2026. Verfasst von Fatemeh Khodabakhshi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran. Hauptthemen laut MEDLINE: Antineoplastic Agents, Cobalt, Coordination Complexes, Thiourea. Die Arbeit nennt 70 Literaturangaben.
Abstract (Originalsprache)
Breast cancer remains a leading cause of cancer‐related mortality worldwide, highlighting the need for novel therapeutic agents with improved selectivity and multifunctional activity. In this study, a novel cobalt(III) complex, Co(L2) 3 [L2 = 2‐chloro‐N‐(2,2‐dimethyloxazolidine‐3‐carbonothioyl)benzamide], was synthesized and evaluated using integrated in vitro and in silico approaches. The ligand and complex were characterized by FT‐IR, UV–Vis, and 1 H NMR spectroscopy. The antiproliferative activity was assessed in MCF‐7, MDA‐MB‐231, and HUVEC cells using the MTT assay. IC 50 values were 176.95 ± 2.84 µg/mL for MCF‐7, 187.01 ± 0.47 µg/mL for MDA‐MB‐231, and 354.96 ± 1.14 µg/mL for HUVEC cells, corresponding to selectivity indices of 2.01 and 1.90, respectively. Co(L2) 3 reduced colony formation and cell migration and increased glutathione reductase activity. Gene expression analysis showed upregulation of CASP3 and CASP9 and downregulation of BCL2, CDC25A, MMP2, and MMP9, indicating modulation of apoptosis‐, cell‐cycle‐, and metastasis‐related responses. Molecular docking predicted favorable interactions with CDC25A, MMP‐2, and MMP‐9. Collectively, these findings indicate that Co(L2) 3 exhibits preferential in vitro anticancer activity against the tested breast cancer cell lines and warrant further investigation as a potential multifunctional anticancer agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran.
- Department of Chemistry, University of Sistan and Baluchestan, Zahedan, Iran.
- Department of Organic Chemistry, Faculty of Chemistry, Alzahra University, Tehran, Iran.
- Department of Chemical Engineering, Faculty of Engineering and Natural Sciences, Süleyman Demirel University, Isparta, Türkiye.
ORCID-Profile: Somayeh Reiisi, Mehran Feizi-Dehnayebi
Zitieren
APA
Khodabakhshi, F., Reiisi, S., Rakhshani, S., & Feizi-Dehnayebi, M. (2026). Anticancer Effect of Co(III) Complex of a Thiourea Derivative on Inhibiting Breast Cancer Cell Proliferation Using In Silico and In Vitro Evaluations. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70544
Vancouver
Khodabakhshi F, Reiisi S, Rakhshani S, Feizi-Dehnayebi M. Anticancer Effect of Co(III) Complex of a Thiourea Derivative on Inhibiting Breast Cancer Cell Proliferation Using In Silico and In Vitro Evaluations. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70544
BibTeX
@article{Khodabakhshi2026,
author = {Khodabakhshi, Fatemeh and Reiisi, Somayeh and Rakhshani, Sajjad and Feizi-Dehnayebi, Mehran},
title = {Anticancer Effect of Co(III) Complex of a Thiourea Derivative on Inhibiting Breast Cancer Cell Proliferation Using In Silico and In Vitro Evaluations},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {20},
doi = {10.1002/cmdc.70544}
}
EUVIMED